GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Short-Term Capital Lease Obligation

Incanthera (AQSE:INC) Short-Term Capital Lease Obligation : £0.00 Mil (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Incanthera Short-Term Capital Lease Obligation?

Incanthera's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2023 was £0.00 Mil.

Incanthera Short-Term Capital Lease Obligation Historical Data

The historical data trend for Incanthera's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Short-Term Capital Lease Obligation Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Short-Term Capital Lease Obligation
- - - -

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Short-Term Capital Lease Obligation Get a 7-Day Free Trial - - - - -

Incanthera Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Incanthera Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Incanthera's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Incanthera (AQSE:INC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
LSE:GENF LSE:EVG LSE:APTA LSE:FAB LSE:IXI LSE:RENE LSE:CIZ LSE:OCTP LSE:IMM LSE:NFX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
76 King Street, Manchester, GBR, M2 4NH
Website
http://www.incanthera.com
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines